Acta Vet. Brno 2024, 93: 259-267

https://doi.org/10.2754/avb202493030259

Onset of immunity of a quadrivalent vaccine against bovine respiratory diseases

Matt Yarnall1, Edmond Jolivet2, Mathieu Chevalier2, Francois Enchéry2, Arnaud Bolon2, Marie-Pascale Tiberghien3, Milan Huňady4, Corinne Philippe2

1Boehringer Ingelheim Vetmedica GmbH, Ingelheim, Germany
2Boehringer Ingelheim, Lyon, France
3Consulting, Cortambert, France
4Bioveta, a.s., Ivanovice na Hané, Czech Republic

Received November 22, 2023
Accepted July 11, 2024

Four experiments demonstrated the onset of immunity at 42 days of a vaccine including the following components: bovine viral diarrhoea virus (BVDV), bovine respiratory syncytial virus (BRSV), bovine parainfluenza (Pi3) and Mannheimia haemolytica (MH). Colostrum-deprived calves were vaccinated at 2 and 5 weeks of age and challenged with virulent strains 6 weeks after the 1st vaccine injection. The challenge strains caused respiratory symptoms in unvaccinated animals, while the vaccinates were clinically protected and excreted much reduced quantities of viral particles in the viral challenge tests. The MH experiment also demonstrated protection in vaccinated animals against clinical signs, lung lesions, and presence of the pathogen in the lungs.

Funding

All three studies were financed by Boehringer Ingelheim and all authors are in the direct or indirect (MPT) employment of Boehringer Ingelheim.

References

12 live references